Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | DPP4 | P27487 | 8/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.41 |
| ▸ | FAP | Q12884 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | HRH2 | P25021 | 2/20 | 0.39 |
| ▸ | HRH1 | P35367 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14148845 | 0.88 | — | — | |
| SCHEMBL23996277 | 0.84 | DPP4 (0.44) | CHRM1DPP4DPP8DPP9DPP7 | |
| SCHEMBL30484009 | 0.81 | HTR1A (0.46) | CHRM1DPP4DPP8DPP9DPP7 | |
| SCHEMBL18887809 | 0.81 | EPHX2 (0.47) | CHRM1HRH3KCNH2CYP2D6 | |
| SCHEMBL18195124 | 0.81 | CYP2C19 (0.50) | CHRM1HRH3KCNH2CYP2D6 | |
| SCHEMBL13300932 | 0.80 | CHRM1 (0.45) | CHRM1DPP4DPP8DPP9DPP7 | |
| SCHEMBL22253828 | 0.80 | CHRM1 (0.45) | CHRM1DPP4DPP8DPP9DPP7 | |
| SCHEMBL1706659 | 0.80 | DPP7 (0.49) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL1189924 | 0.80 | DPP7 (0.49) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL28132609 | 0.80 | DPP7 (0.49) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023141300-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | KUMQUAT BIOSCIENCES INC. (US) | 2023-07-27 | — | — | WO | disclosed |